113 related articles for article (PubMed ID: 30415795)
1. Relation of CHA
Ogunbayo GO; Pecha R; Misumida N; Hillerson D; Elbadawi A; Abdel-Latif A; Elayi CS; Messerli AW; Smyth SS
Am J Cardiol; 2019 Jan; 123(2):212-217. PubMed ID: 30415795
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends, characteristics and outcomes of fibrinolytic therapy for ST-elevation myocardial infarction among patients 80 years or older.
Ogunbayo GO; Misumida N; Ayoub K; Hailemariam Y; Hillerson D; Elbadawi A; Abdel-Latif A; Smyth S; Ziada K; Messerli AW
Catheter Cardiovasc Interv; 2018 Dec; 92(7):E425-E432. PubMed ID: 30269436
[TBL] [Abstract][Full Text] [Related]
3. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
[TBL] [Abstract][Full Text] [Related]
5. Effect of Chronic Hematologic Malignancies on In-Hospital Outcomes of Patients With ST-Segment Elevation Myocardial Infarction.
Patel G; Pancholy N; Thomas L; Rai A; Kher A; Peters C; Amin A; Patel TM; Pancholy S
Am J Cardiol; 2019 Aug; 124(3):349-354. PubMed ID: 31196560
[TBL] [Abstract][Full Text] [Related]
6. Management Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients Transferred After Receiving Fibrinolytic Therapy in the United States.
Patel N; Patel NJ; Thakkar B; Singh V; Arora S; Patel N; Savani C; Deshmukh A; Thadani U; Badheka AO; Alfonso C; Fonarow GC; Cohen MG
Clin Cardiol; 2016 Jan; 39(1):9-18. PubMed ID: 26785349
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of fibrinolytic therapy for patients with metastatic cancer and acute pulmonary embolism.
Ogunbayo GO; Pecha R; Misumida N; Goodwin E; Ayoub K; Hillerson D; Elbadawi A; Abdel-Latif A; Elayi CS; Messerli AW; Smyth SS
Pulm Pharmacol Ther; 2019 Jun; 56():104-107. PubMed ID: 30959093
[TBL] [Abstract][Full Text] [Related]
9. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials).
Ahmed S; Antman EM; Murphy SA; Giugliano RP; Cannon CP; White H; Morrow DA; Braunwald E
J Thromb Thrombolysis; 2006 Apr; 21(2):119-29. PubMed ID: 16622607
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
11. Stroke prediction with an adjusted R-CHA2DS2VASc score in a cohort of patients with a Myocardial Infarction.
Barra S; Almeida I; Caetano F; Providência R; Paiva L; Dinis P; Leitão Marques A
Thromb Res; 2013 Aug; 132(2):293-9. PubMed ID: 23928474
[TBL] [Abstract][Full Text] [Related]
12. Acute Myocardial Infarction Outcomes in Systemic Lupus Erythematosus (from the Nationwide Inpatient Sample).
Ando T; Adegbala O; Akintoye E; Ashraf S; Briasoulis A; Takagi H; Afonso L
Am J Cardiol; 2019 Jan; 123(2):227-232. PubMed ID: 30424870
[TBL] [Abstract][Full Text] [Related]
13. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
[TBL] [Abstract][Full Text] [Related]
14. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
15. Rate and impact of venous thromboembolism in patients with ST-segment elevation myocardial infarction: Analysis of the Nationwide Inpatient Sample database 2003-2013.
Al-Ogaili A; Ayoub A; Diaz Quintero L; Torres C; Fuentes HE; Fugar S; Kolkailah AA; Dakkak W; Tafur AJ; Yadav N
Vasc Med; 2019 Aug; 24(4):341-348. PubMed ID: 30915913
[TBL] [Abstract][Full Text] [Related]
16. Intracranial hemorrhage after carotid endarterectomy and carotid stenting in the United States in 2005.
Timaran CH; Veith FJ; Rosero EB; Modrall JG; Valentine RJ; Clagett GP
J Vasc Surg; 2009 Mar; 49(3):623-8; discussion 628-9. PubMed ID: 19268766
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
[TBL] [Abstract][Full Text] [Related]
18. Delays in fibrinolysis as primary reperfusion therapy for acute ST-segment elevation myocardial infarction.
Glickman SW; Cairns CB; Chen AY; Peterson ED; Roe MT
Am Heart J; 2010 Jun; 159(6):998-1004.e2. PubMed ID: 20569712
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study).
Huynh T; Montigny M; Iftikhar U; Gagnon R; Eisenberg M; Lauzon C; Mansour S; Rinfret S; Afilalo M; Nguyen M; Kouz S; Déry JP; Harvey R; De LaRocheliere R; Cantin B; Schampaert E; Tardif JC
Am J Cardiol; 2018 Apr; 121(8):897-902. PubMed ID: 29452691
[TBL] [Abstract][Full Text] [Related]
20. Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared with catheter-directed intervention for the treatment of acute pulmonary embolism.
Liang NL; Avgerinos ED; Singh MJ; Makaroun MS; Chaer RA
J Vasc Surg Venous Lymphat Disord; 2017 Mar; 5(2):171-176.e1. PubMed ID: 28214483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
